Foxp3 confers long-term efficacy of chimeric antigen receptor-T cells via metabolic reprogramming
Foxp3 conferslong-term efficacyof chimeric antigenreceptor-T cells via metabolic reprogramming
Acquisition of Vimentin by trogocytosis inhibits the NK cell-mediated immune response against circulating tumour cells (CTCs)
E-twenty-six-specific sequence variant 5 (ETV5) facilitates hepatocellular carcinoma progression and metastasis through enhancing polymorphonuclear myeloid-derived suppressor cell (PMN-MDSC)-mediated immunosuppression
SAICAR Drives T Regulatory Cell Differentiation and FOXP3 Maintenance to Promote Immunotherapy Resistance
Palmitic acid-triggered B7H3 palmitoylation promotes immune escape